Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 0.62 |
| ▸ | CYBB | P04839 | 2/20 | 0.61 |
| ▸ | NOX3 | Q9HBY0 | 2/20 | 0.61 |
| ▸ | NOX4 | Q9NPH5 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 7/20 | 0.59 |
| ▸ | GAA | P10253 | 6/20 | 0.59 |
| ▸ | SNCA | P37840 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | BCHE | P06276 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | CNR1 | P21554 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20664930 | 0.91 | SNCA (0.50) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL30336020 | 0.91 | SNCA (0.50) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL25898787 | 0.90 | NOX1 (0.71) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL28110666 | 0.88 | NOX1 (0.58) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL885158 | 0.85 | NOX1 (0.57) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL30811565 | 0.84 | NOX1 (0.84) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL10372692 | 0.84 | NOX1 (0.84) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL1718166 | 0.84 | NOX1 (0.55) | NOX1CYBBNOX3NOX4MAPT | |
| Phenothiazine SCHEMBL4288768 | 0.84 | ALOX15 (0.58) | NOX1CYBBNOX3NOX4MAPT | |
| SCHEMBL1718554 | 0.83 | NOX1 (0.54) | NOX1CYBBNOX3NOX4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2998303-B1 | PHENOTHIAZINE DERIVATIVES AND METHODS FOR TREATING TUMORS | B & G PARTNERS LLC (US) | 2018-06-13 | — | — | EP | disclosed |
| EP-2998303-A1 | PHENOTHIAZINE DERIVATIVES AND METHODS FOR TREATING TUMORS | B & G Partners, LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9198916-B1 | Compounds and methods for treating tumors | B&G PARTNERS, LLC (US) | 2015-12-01 | — | — | US | disclosed |
| US-8148565-B2 | Method of manufacturing an organic silicon compound that contains a methacryloxy group or an acryloxy group | DOW CORNING TORAY COMPANY, LTD. (JP) | 2012-04-03 | — | — | US | disclosed |
| EP-1915384-B1 | A METHOD OF MANUFACTURING AN ORGANIC SILICON COMPOUND THAT CONTAINS A METHACRYLOXY GROUP OR AN ACRYLOXY GROUP | DOW CORNING TORAY CO LTD (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-20090306370-A1 | Method Of Manufacturing An Organic Silicon Compound That Contains A Methacryloxy Group Or An Acryloxy Group | DOW TORAY CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-1915384-A1 | A METHOD OF MANUFACTURING AN ORGANIC SILICON COMPOUND THAT CONTAINS A METHACRYLOXY GROUP OR AN ACRYLOXY GROUP | Dow Corning Toray Co., Ltd. (JP) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007020932-A1 | A METHOD OF MANUFACTURING AN ORGANIC SILICON COMPOUND THAT CONTAINS A METHACRYLOXY GROUP OR AN ACRYLOXY GROUP | DOW CORNING TORAY CO., LTD. (JP) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306370-A1 | Method Of Manufacturing An Organic Silicon Compound That Contains A Methacryloxy Group Or An Acryloxy Group | SIK1, SMS, SIK2 | NOX1 3375/4885CYBB 3891/4885NOX3 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.